Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E FREI

Showing results (391-400 of 428) with videos related to

Pageof 43
Sort By:
Haematology and Blood Transfusion|January 1, 1983
The treatment of acute myelogenous leukemia in children and adults: VAPA updateH J Weinstein, R J Mayer, D S Rosenthal, et al.
Journal of the National Cancer Institute|April 7, 1993
Intensive combined modality therapy for limited-stage small-cell lung cancerA D Elias, L Ayash, E Frei, et al.
Chest|April 1, 1993
High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancerA D Elias, L Ayash, A T Skarin, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I studyA D Elias, L J Ayash, J P Eder, et al.
JAMA|July 28, 1993
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group BR B Weiss, N J Vogelzang, B A Peterson, et al.
Surgical Endoscopy|December 1, 2001
Randomized controlled trial of laparoscopic transabdominal preperitoneal hernioplasty vs Shouldice repairJ F Tschudi, M Wagner, C Klaiber, et al.
American Journal of Clinical Oncology|February 1, 1994
Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term resultsA D Elias, A T Skarin, R Gonin, et al.
Cancer Treatment Reports|May 1, 1983
Phase I trial of mitoxantrone by 24-hour continuous infusionK C Anderson, M B Garnick, M W Meshad, et al.
The New England Journal of Medicine|September 8, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppressionK S Antman, J D Griffin, A Elias, et al.
Cancer Treatment Reports|November 1, 1979
Phase I trial of bruceantinM B Garnick, R H Blum, G P Canellos, et al.
Pageof 43

Showing results (391-400 of 428) with videos related to

Sort By:
Pageof 43
Haematology and Blood Transfusion|January 1, 1983
The treatment of acute myelogenous leukemia in children and adults: VAPA updateH J Weinstein, R J Mayer, D S Rosenthal, et al.
Journal of the National Cancer Institute|April 7, 1993
Intensive combined modality therapy for limited-stage small-cell lung cancerA D Elias, L Ayash, E Frei, et al.
Chest|April 1, 1993
High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancerA D Elias, L Ayash, A T Skarin, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I studyA D Elias, L J Ayash, J P Eder, et al.
JAMA|July 28, 1993
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group BR B Weiss, N J Vogelzang, B A Peterson, et al.
Surgical Endoscopy|December 1, 2001
Randomized controlled trial of laparoscopic transabdominal preperitoneal hernioplasty vs Shouldice repairJ F Tschudi, M Wagner, C Klaiber, et al.
American Journal of Clinical Oncology|February 1, 1994
Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term resultsA D Elias, A T Skarin, R Gonin, et al.
Cancer Treatment Reports|May 1, 1983
Phase I trial of mitoxantrone by 24-hour continuous infusionK C Anderson, M B Garnick, M W Meshad, et al.
The New England Journal of Medicine|September 8, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppressionK S Antman, J D Griffin, A Elias, et al.
Cancer Treatment Reports|November 1, 1979
Phase I trial of bruceantinM B Garnick, R H Blum, G P Canellos, et al.
Pageof 43